The ups and downs of multiple sclerosis therapeutics
2001; Wiley; Volume: 49; Issue: 3 Linguagem: Inglês
10.1002/ana.61
ISSN1531-8249
AutoresReinhard Hohlfeld, Heinz Wiendl,
Tópico(s)Rheumatoid Arthritis Research and Therapies
ResumoAnnals of NeurologyVolume 49, Issue 3 p. 281-284 Editorial The ups and downs of multiple sclerosis therapeutics Reinhard Hohlfeld MD, Reinhard Hohlfeld MD Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, Klinikum Grosshadern Munich, GermanySearch for more papers by this authorHeinz Wiendl MD, Heinz Wiendl MD Department of Neurology, University of Tübingen Tübingen, GermanySearch for more papers by this author Reinhard Hohlfeld MD, Reinhard Hohlfeld MD Institute for Clinical Neuroimmunology, Ludwig-Maximilians University, Klinikum Grosshadern Munich, GermanySearch for more papers by this authorHeinz Wiendl MD, Heinz Wiendl MD Department of Neurology, University of Tübingen Tübingen, GermanySearch for more papers by this author First published: 01 March 2001 https://doi.org/10.1002/ana.61Citations: 46Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume49, Issue31 March 2001Pages 281-284 RelatedInformation
Referência(s)